Recently, several emerging biomarkers such as neutrophil to lymphocyte ratio (NLR) [1, 13], platelet to lymphocyte ratio (PLR) [14] and C-reactive protein to lymphocyte ratio (CLR) [15] were used to assess COVID-19 progression and were more specific in the early triage of admission than was routine laboratory testing [16]. Here, CRP is linked to COVID-19.